Skip to main content
Proceedings (Baylor University. Medical Center) logoLink to Proceedings (Baylor University. Medical Center)
letter
. 2020 Jul 6;33(3):474. doi: 10.1080/08998280.2020.1765666

The authors respond

Amr Idris 1, Karim M Al-Azizi 1,
PMCID: PMC7340466  PMID: 32675995

We would like to thank the authors of the letter for their interest in our paper.1 Mental disorders are a major cause of morbidity, and patients with mental health disorders have a higher incidence of takotsubo cardiomyopathy (TC). We agree with the authors that our patient had a combination of both emotional and physical stressors. Norepinephrine and dopamine have been implicated as neurotransmitters in acute mania.2 Most TC patients recognize stress events as frightening experiences, leading to the increase of the bioavailability of catecholamines.3 Several theories suggest the importance of the catecholamine surge in the pathogenesis of TC.4 Our patient abruptly stopped her prescribed medications for bipolar disorder, which led to her acute manic attack and contributed to her emotional and psychological stress. Her acute mania manifested as sleep deprivation and poor oral intake, which resulted in rhabdomyolysis as a physical stress likely triggering the abrupt increase in catecholamine levels.

As mentioned by the authors, severe adrenergic discharge might be associated with malignant arrhythmia. Fortunately, our patient did not have any documented arrhythmia during her hospitalization or as an outpatient. Her echocardiogram also did not show left ventricular outflow tract obstruction.

Coronary microvascular dysfunction has been suggested as the underlying mechanism in some TC patients and has been reported in multiple diagnostic tools.5 Conflicting results have been reported regarding reduced Thrombolysis in Myocardial Infarction (TIMI) frame count in TC patients for assessing microvascular dysfunction.6,7 Our patient’s coronary angiography showed normal filling in the left anterior descending artery, in the left circumflex artery, and in the right coronary artery.

Given the chronic nature of psychiatric illnesses with the risk of acute flare-ups, TC has a higher recurrence in these patients.8,9 As such, a patient-centered multidisciplinary approach including a primary care physician, cardiologist, and psychiatrist should be emphasized in the care of these patients with close follow-up to avoid further acute psychiatric attacks and decrease the rate of TC recurrence. Our patient did not have recurrence after her initial episode of TC. Therefore, invasive treatments including sympathetic ganglion blockade were avoided and not considered at the time. Unfortunately, there are no current trials evaluating the treatment of TC, and guideline-directed medical therapy for heart failure is the current standard of care for TC patients.

—Amr Idris, MD and Karim M. Al-Azizi, MD
The Heart Hospital Baylor Plano, Plano, Texas
E-mail: karim.alazizi@bswhealth.org

References

  • 1.Idris A, Christensen JL, Hamandi M, et al. Takotsubo cardiomyopathy and acute manic attack. Proc (Bayl Univ Med Cent). 2020;33(1):80–82. doi: 10.1080/08998280.2019.1686912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Steptoe A, Kivimäki M. Stress and cardiovascular disease. Nat Rev Cardiol. 2012;9(6):360–370. doi: 10.1038/nrcardio.2012.45. [DOI] [PubMed] [Google Scholar]
  • 3.Kurita M. Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode. Neuropsychiatr Dis Treat. 2016;12:2373–2380. doi: 10.2147/NDT.S109835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of takotsubo syndrome. Circulation. 2017;135(24):2426–2441. doi: 10.1161/CIRCULATIONAHA.116.027121. [DOI] [PubMed] [Google Scholar]
  • 5.Vitale C, Rosano GM, Kaski JC. Role of coronary microvascular dysfunction in takotsubo cardiomyopathy. Circ J. 2016;80(2):299–305. doi: 10.1253/circj.CJ-15-1364. [DOI] [PubMed] [Google Scholar]
  • 6.Khalid N, Iqbal I, Coram R, Raza T, Fahsah I, Ikram S. Thrombolysis in Myocardial Infarction frame count in takotsubo cardiomyopathy. Int J Cardiol. 2015;191:107–108. doi: 10.1016/j.ijcard.2015.04.192. [DOI] [PubMed] [Google Scholar]
  • 7.Loffi M, Santangelo A, Kozel M, et al. Takotsubo cardiomyopathy: one more angiographic evidence of microvascular dysfunction. Biomed Res Int. 2018;2018:5281485. doi: 10.1155/2018/5281485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–938. doi: 10.1056/NEJMoa1406761. [DOI] [PubMed] [Google Scholar]
  • 9.Nayeri A, Rafla-Yuan E, Farber-Eger E, et al. Pre-existing psychiatric illness is associated with increased risk of recurrent takotsubo cardiomyopathy. Psychosomatics. 2017;58(5):527–532. doi: 10.1016/j.psym.2017.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings (Baylor University. Medical Center) are provided here courtesy of Baylor University Medical Center

RESOURCES